¥420 million fine eyed for 3 drug wholesalers
17:29 JST, February 7, 2022
TOKYO (Jiji Press) — Japan’s Fair Trade Commission plans to order three major drug wholesalers to pay a total of about ¥420 million in fines for rigging bids for contracts to supply ethical drugs to an independent administrative body, according to informed sources.
The three companies found to have violated the antimonopoly law are Alfresa Corp., Toho Pharmaceutical Co. and Suzuken Co.
The FTC will also urge the companies to take measures to prevent a recurrence of such wrongdoing, the sources said Sunday.
Late last month, the commission notified the companies of the punishment plan. It will make a final decision after hearing opinions from them.
In November 2019, the FTC raided the three companies and Mediceo Corp.
The Tokyo District Public Prosecutors Office’s special investigation team indicted Alfresa and Toho, both based in Tokyo, as well as Suzuken, headquartered in Nagoya. Tokyo-based Mediceo was exempted from indictment as the company voluntarily reported the bid-rigging.
"Society" POPULAR ARTICLE
-
Japan Court OKs Sex Change without Surgery
-
3 Climbers Die On Mt. Fuji Within 2 Days Of Opening; Japan Police, Guides Urge Climbers To Prepare Well, Make Wise Decisions
-
Sex Crime Perpetrators Linked to U.S. Military in 166 Cases in Japan over 35 years; Local, Prefectural Governments Often Not Aware of Crimes
-
New Mt. Fuji Rules Reduce ‘Bullet Climbers’ by 90%; Access to Japan’s Iconic Peak Limited from Yamanashi Pref. Side
-
Tokaido Shinkansen Trains Suspended Between Hamamatsu and Nagoya Due to Accident; Resuming Services Expected Noon at Earliest
JN ACCESS RANKING